AARON GREENE: Open Payments
NPI 1598902314 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 113 payments from 12 companies in 2025. Trend: 2023 $1,824 · 2024 $1,511 · 2025 $1,869
Food & beverage: $1,869
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $512 |
| ABBVIE INC. | 25 | $235 |
| Vanda Pharmaceuticals Inc. | 18 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $171 |
| Axsome Therapeutics, Inc. | 11 | $171 |
| Lundbeck LLC | 8 | $163 |
| Janssen Pharmaceuticals, Inc | 5 | $142 |
| Neurocrine BioSciences, Inc. | 5 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, Auvelity, FANAPT, INGREZZA, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
